Skip to main content
SpringerLink
Log in

Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Gastric mucosa-associated lymphoid tissue (MALT) lymphoma and diffuse large B cell lymphoma (DLBCL) show a spectrum of disease characterized by varying proportions of low-grade and high-grade components. While the natural history and optimum treatment for low-grade gastric MALT lymphoma and DLBCL is well established, the prognosis and optimal treatment of patients with both low- and high-grade components is not well established. The purpose of our study was to evaluate the clinical characteristics, survival outcomes, and prognostic factors of patients with gastric MALT lymphoma and gastric DLBCL. A retrospective review of patients with gastric MALT lymphoma, gastric DLBCL, or MALT lymphoma with a high-grade component treated at our centers from 1994 to 2006 was performed. Patients were divided into three categories: “pure MALT lymphoma,” “MALT lymphoma with high-grade component” (mixed), and “pure DLBCL.” Seventy-six patients were included in our study—26 with pure MALT, 22 with MALT with high-grade component (“mixed”), and 28 with pure DLBCL. Pure MALT lymphoma and mixed lymphoma patients had similar clinical characteristics, whereas pure DLBCL patients had less favorable disease characteristics with significantly poorer performance status, higher number of extranodal sites of disease, higher stage, and larger proportion of bone marrow involvement and international prognostic index (IPI) scores compared with mixed lymphoma. The majority of mixed lymphoma (72.7%) and DLBCL patients (71.4%) were treated with chemotherapy. Of patients receiving chemotherapy, a higher proportion of mixed lymphoma and DLBCL patients received anthracycline-based combination chemotherapy regimens compared with MALT lymphoma (73% vs 71% vs 8%) whereas the proportion of mixed lymphoma and DLBCL patients was similar (p = 0.919). At a median follow-up of 37 months, the 5-year overall survival was 66.9%. The 5-year overall survival was 78% for MALT lymphoma, 84% for mixed lymphoma, and 45% for DLBCL. On univariate analysis, DLBCL histology, age, performance status, serum albumin, lactate dehydrogenase, bone marrow, number of extranodal sites, stage, and IPI score were prognostic for inferior survival. On multivariate analysis, DLBCL histology remained significantly prognostic for inferior survival, independent of chemotherapy regimen (hazard ratio (HR) 6.66, 95% confidence interval (CI) 2.01–21.41, p = 0.001). Mixed histology was not prognostic for inferior survival (HR 1.13, 95% CI 0.28–4.54, p = 0.868). Other factors prognostic for inferior survival were serum albumin <37 g/L (HR 3.22, 95% CI 1.11–13.22, p = 0.034) and treatment with non-cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy (HR 4.89, 95% CI 1.67–14.36, p = 0.004). In conclusion, the clinical characteristics of mixed histology MALT lymphoma are similar to low-grade MALT lymphoma and significantly different from pure DLBCL. The prognosis of mixed histology MALT lymphoma is significantly better than pure DLBCL, independent of IPI and chemotherapy regimen, and pure DLBCL histology is independently prognostic of inferior survival outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Isaacson PG (1994) Gastrointestinal lymphoma. Hum Pathol 25:1020–1029

    Article  PubMed  CAS  Google Scholar 

  2. Aisenberg AC (1995) Coherent view of non-Hodgkin’s lymphoma. J Clin Oncol 13:2656–2675

    PubMed  CAS  Google Scholar 

  3. Crump M, Gospodaroricz M, Shepherd FA (1999) Lymphoma of the gastrointestinal tract. Semin Oncol 26:324–337

    PubMed  CAS  Google Scholar 

  4. Ang MK, Tao M, Quek R, Sng I, Tan L, Lim ST (2007) MALT lymphomas show different behaviour and clinical outcomes depending on their primary location. Poster Presentation for Lancet Asia Medical Forum 2007

  5. Zucca E, Roggero E, Pileri S (1998) B-cell lymphoma of MALT type: a review with special emphasis on diagnostic and management problems of low grade gastric tumours. Br J Haematol 100:3–14

    Article  PubMed  CAS  Google Scholar 

  6. Neubauer A, Thiede C, Morgner A, Alpen B, Ritter M, Neubauer B, Wundisch T, Ehninger G, Stolte M, Bayerdorffer E (1997) Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma. J Nat Cancer Inst 89:1350–1355

    Article  PubMed  CAS  Google Scholar 

  7. Cogliatti S, Schmid U, Schumacher U, Eckert F, Hansmann ML, Hedderich J, Takahashi H, Lennert K (1991) Primary B-cell gastric lymphoma: a clinicopathological study of 145 patients. Gastroenterology 101:1159–1170

    PubMed  CAS  Google Scholar 

  8. Lim ST, Tao M, Cheung YB, Rajan S, Mann B (2005) Can patients with early-stage diffuse large B-cell lymphoma be treated without bone marrow biopsy? Ann Oncol 16:215–218

    Article  PubMed  CAS  Google Scholar 

  9. The International Non-Hodgkin’s Lymphoma Prognostic Factors Project (1993) A predictive model for aggressive non-Hodgkin’s lymphoma. N Engl J Med 329:987–994

    Article  Google Scholar 

  10. Isaacson PG (1996) Recent development in our understanding of gastric lymphoma. Am J Surg Pathol 20:S1–S7

    PubMed  Google Scholar 

  11. De Jong D, Boot J, Van Heerde P, Hart GAM, Taal BG (1997) Histological grading in gastric lymphoma: pretreatment criteria and clinical relevance. Gastroenterology 112:1466–1474

    Article  PubMed  Google Scholar 

  12. Hussell T, Isaacson PG, Crabtree JE, Spencer J (1993) The response of cells from low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 342:571–574

    Article  PubMed  CAS  Google Scholar 

  13. Isaacson PG (1999) Gastric MALT lymphoma: from concept to cure. Ann Oncol 10:637–645

    Article  PubMed  CAS  Google Scholar 

  14. Zucca E, Bertoni F, Roggero E, Cavalli F (2000) The gastric marginal zone B-cell lymphoma of MALT type. Blood 96:410–419

    PubMed  CAS  Google Scholar 

  15. Bayerdorffer E, Rudolph B, Neubauer A, Thiede C, Lehn N, Eidt S, Stolte M, MALT Lymphoma Study Group (1995) Regression of primary gastric lymphoma of mucosa associated lymphoid tissue type after cure of Helicobacter pylori infection. Lancet 345:1591–1594

    Article  PubMed  CAS  Google Scholar 

  16. Nakamura S, Akazawa K, Yao T, Tsuneyoshi M (1995) Primary gastric lymphoma. A clinicopathologic study of 233 cases with special reference to evaluation with the MIB-1 index. Cancer 76:1313–1324

    Article  PubMed  CAS  Google Scholar 

  17. Nakamura S, Matsumoto T, Suekane H, Nakamura S, Matsumoto H, Esaki M, Yao T, Iida M (2005) Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment. Cancer 103:532–540

    Article  Google Scholar 

  18. Morton JE, Leyland MJ, Vaughan Hudson G, Vaughan Hudson B, Anderson L, Bennet MH, MacLennan KA (1993) Primary gastrointestinal non-Hodgkin’s lymphoma: a review of 175 British National Lymphoma Investigation cases. Br J Cancer 67:776–782

    PubMed  CAS  Google Scholar 

  19. Wotherspoon AC, Ortoz-Hidalgo C, Falzon MR, Isaacson PG (1991) Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 338:1175–1176

    Article  PubMed  CAS  Google Scholar 

  20. Roggero E, Zucca E, Pinotti G, Pascarella A, Capella C, Savio A, Pedrinis E, Paterlini A, Venco A, Cavalli F (1995) Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue. Ann Intern Med 122:767–769

    PubMed  CAS  Google Scholar 

  21. Montalban C, Santon A, Boixeda D, Redondo C, Alvarez I, Calleja JL, de Argila CM, Bellas C (2001) Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long term results after sequential histologic and molecular follow-up. Haematologica 86:609–617

    PubMed  CAS  Google Scholar 

  22. Fischbach W, Goebeler-Kolve ME, Dragosics B, Greiner A, Stolte M (2004) Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series. Gut 53:34–37

    Article  PubMed  CAS  Google Scholar 

  23. De Jong D, Aleman BM, Taal BG, Boot H (1999) Controversies and consensus in the diagnosis, work-up and treatment of gastric lymphoma: an international survey. Ann Oncol 10:275–280

    Article  PubMed  Google Scholar 

  24. Chen L-T, Lin J-T, Tai JJ, Chen G-H, Yeh H-Z, Yang S-S, Wang H-P, Kuo S-H, Sheu B-S, Jan C-M, Wang W-M, Wang T-E, Wu C-W, Chen C-L, Su I-J, Whang-Peng J, Cheng A-L (2005) Long term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma. J Nat Cancer Inst 97:1345–1353

    Article  PubMed  CAS  Google Scholar 

  25. Morgner A, Miehlke S, Fischbach W, Schmitt W, Muller-Hermelink H, Greiner A, Thiede C, Schetelig J, Neubauer A, Stolte M, Ehninger G, Bayerdorffer E (2001) Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection. J Clin Oncol 19:2041–2048

    PubMed  CAS  Google Scholar 

  26. Chen L-T, Lin J-T, Shyu R-Y, Jan C-M, Chen C-L, Chiang I-P, Liu S-M, Su I-J, Cheng A-L (2001) Prospective study of Helicobacter pylori eradication therapy in stage IE high-grade mucosa-associated lymphoid tissue lymphoma of the stomach. J Clin Oncol 19:4245–4251

    PubMed  CAS  Google Scholar 

  27. Nakamura S, Matumoto T, Suekane H, Takeshita M, Hizawa K, Kawasaki M, Yao T, Tsunetoshi M, Iida M, Fujishima M (2001) Predictive value of endoscopic ultrasonography for regression of gastric low-grade and high-grade MALT lymphomas after eradication of Helicobacter pylori. Gut 48:454–460

    Article  PubMed  CAS  Google Scholar 

  28. Miki H, Hideo S, Harada H, Yamanoi Y, Uraoka T, Sotozono M, Ohmori M (2001) Early stage gastric MALT lymphoma with high-grade component cured by Helicobacter pylori eradication. J Gastroenterol 36:121–124

    Article  PubMed  CAS  Google Scholar 

  29. Montalban C, Santon A, Boixeda D, Bellas C (2001) Regression of gastric high-grade mucosa associated lymphoid tissue (MALT) lymphoma after Helicobacter pylori eradication. Gut 49:584–587

    Article  PubMed  CAS  Google Scholar 

  30. Jaffe ES, Harris NL, Sha VJ (eds) (2001) In: Tumours of haematopoietic and lymphoid tissues. World Health Organization Classification of Tumors. IARC Press, Lyon, pp 171–176

  31. Chan JK, Ng CS, Isaacson PG (1990) Relationship between high-grade lymphoma and low-grade B cell lymphoma of mucosa-associated lymphoid tissue (MALToma) of the stomach. Am J Pathol 136:1153–1164

    PubMed  CAS  Google Scholar 

  32. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD (1999) World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting—Airlie House, Virginia, November 1997. J Clin Oncol 17:3835–3849

    PubMed  CAS  Google Scholar 

  33. Musshoff K, Klinische Stadieneinteilung der nicht (1977) Hodgkin’s lymphoma. Strahlenthreapie Onkol 153:218–221

    CAS  Google Scholar 

  34. Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, Lister TA, Vose J, Grillo-Lopez G, Hagenbeek A, Cabanillas F, Klippensten D, Hiddemann W, Castellino R, Harris NL, Armitage JO, Carter W, Hoppe R, Canellos GP (1999) Report of an International Workshop to standardize response criteria for non-Hodgkin’s lymphomas. J Clin Oncol 17:1244–1253

    PubMed  CAS  Google Scholar 

  35. Wotherspoon AC, Doglioni C, Diss TC, Pan L, Isaacson PG, Doglioni C, Moschini A, de Boni M (1993) Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342:575–577

    Article  PubMed  CAS  Google Scholar 

  36. Castrillo JM, Montalban C, Obeso G, Piris MA, Rivas MC (1992) Gastric B-cell mucosa associated lymphoid tissue lymphoma: a clinicopathological study in 56 patients. Gut 33:1307–1311

    Article  PubMed  CAS  Google Scholar 

  37. Koch P, del Valle F, Berdel WE, Willich NA, Reers B, Hiddemann W, Grothaus-Pinke B, Reinartz G, Brockmann J, Temmesfeld A, Schmitz R, Rube C, Probst A, Jaenke G, Bodenstein H, Junker A, Pott C, Schultze J, Heinecke A, Parwaresch R, Tiemann M for the German Multicenter Study Group (2001) Primary gastrointestinal non-Hodgkin’s lymphoma: II. combined surgical and conservative or conservative management only in localized gastric lymphoma- results of the prospective German Multicenter Study GIT NHL 01/92. J Clin Oncol 19:3874–3883

    PubMed  CAS  Google Scholar 

  38. Taal BG, Boot H, van Heerde P, de Jong D, Hart AAM, Burgers JMV (1996) Primary non-Hodgkin lymphoma of the stomach: endoscopic pattern and prognosis in low versus high grade malignancy in relation to the MALT concept. Gut 39:556–561

    Article  PubMed  CAS  Google Scholar 

  39. Hsu C, Chen C-L, Chen L-T, Liu H-T, Chen Y-C, Jan C-M, Liu C-S, Cheng A-L (2001) Comparison of MALT and non-MALT primary large cell lymphoma of the stomach. Cancer 19:49–56

    Article  Google Scholar 

  40. Nakamura S, Matsumoto T, Takeshita M, Kurahara K, Yao T, Tsuneyoshi M, Iida M, Fujishima M (2000) A clinicopathologic study of primary small intestine lymphoma. Cancer 88:286–294

    Article  PubMed  CAS  Google Scholar 

  41. Villuendas R, Piris MA, Orradre JL, Mollejo M, Algara P, Sanchez L, Martinez JC, Martinez P (1992) Different bcl-2 protein expression in high-grade B-cell lymphomas derived from lymph node or mucosa associated lymphoid tissue. Am J Pathol 139:989–993

    Google Scholar 

  42. Hoeve MA, Gisbertz IAM, Schouten HC, Schuuring E, Bot FJ, Hermans J, Hopman A, Kluin PhM, Arends J-W, van Krieken JHJM (1999) Gastric low-grade MALT lymphoma, high-grade MALT lymphoma and diffuse large B cell lymphoma show different frequencies of trisomy. Leukemia 13:799–807

    Article  PubMed  CAS  Google Scholar 

  43. Chan W-Y, Wong N, Chan AB, Chow JH, Lee JC (1998) Consistent copy number gain in chromosome 12 in primary diffuse large cell lymphomas of the stomach. Am J Pathol 152:11–16

    PubMed  CAS  Google Scholar 

  44. Ott G, Kalla J, Steinhoff A, Rosenwald A, Katzenberger T, Roblick U, Ott MM, Muller-Hermelink HK (1998) Trisomy 3 is not a common feature in malignant lymphomas of mucosa-associated tissue type. Am J Pathol 152:689–694

    Google Scholar 

  45. Yoshino T, Omonishi K, Kobayashi K, Mannami T, Okada H, Mizuno M, Yamadori I, Kondo E, Akagi T (2000) Clinicopathological features of gastric mucosa associated lymphoid tissue (MALT) lymphomas: high grade transformation and comparison with diffuse large B cell lymphomas without MALT lymphoma features. J Clin Pathol 53:187–190

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Oncology, National Cancer Center Singapore, Singapore, Singapore

    Mei-Kim Ang, Richard Quek, Miriam Tao & Soon Thye Lim

  2. Division of Clinical Trials and Epidemiological Sciences, National Cancer Center Singapore, Singapore, Singapore

    Siew Wan Hee

  3. Department of Radiation Oncology, National Cancer Center Singapore, Singapore, Singapore

    Swee Peng Yap & Susan Loong

  4. Department of Pathology, Singapore General Hospital, Singapore, Singapore

    Leonard Tan

Authors
  1. Mei-Kim Ang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Siew Wan Hee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Richard Quek
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Swee Peng Yap
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Susan Loong
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Leonard Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Miriam Tao
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Soon Thye Lim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Soon Thye Lim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ang, MK., Hee, S.W., Quek, R. et al. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis. Ann Hematol 88, 417–424 (2009). https://doi.org/10.1007/s00277-008-0604-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-008-0604-7

Keywords

Search

Navigation